Moreover, in an in vivo prostate cancer model, a NP-mediated increase in PTEN led to disease remission, highlighting the importance of this gene in tumorigenesis and defining it as a promising therapeutic target and progression marker [56]. The gene discussed is PTEN; the disease is prostate carcinoma.